{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:34:37Z","timestamp":1791531277304,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.lungcan.2022.06.008","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T21:37:25Z","timestamp":1655329045000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas"],"prefix":"10.1016","volume":"170","author":[{"given":"Philipp","family":"Jurmeister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Leitheiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Klauschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Capper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Brcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2022.06.008_b0005","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/ijerph15051000","article-title":"Global Asbestos Disaster","volume":"15","author":"Furuya","year":"2018","journal-title":"Int. J. Environ. Res. Pu."},{"key":"10.1016\/j.lungcan.2022.06.008_b0010","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.3390\/ijerph17186900","article-title":"Burden of Mesothelioma Deaths by National Income Category: Current Status and Future Implications","volume":"17","author":"Chimed-Ochir","year":"2020","journal-title":"Int. J. Environ. Res. Pu."},{"key":"10.1016\/j.lungcan.2022.06.008_b0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2022.06.008_b0020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/0284186X.2012.709948","article-title":"Treatment and survival analyses of malignant mesothelioma in Japan","volume":"52","author":"Gemba","year":"2012","journal-title":"Acta Oncol."},{"key":"10.1016\/j.lungcan.2022.06.008_b0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tranon.2014.12.002","article-title":"Changing Pattern in Malignant Mesothelioma Survival","volume":"8","author":"Faig","year":"2015","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.lungcan.2022.06.008_b0030","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jtho.2018.08.2036","article-title":"Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation","volume":"13","author":"Tsao","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2022.06.008_b0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(09)70134-2","article-title":"on behalf of the W.I.A. for R. on C.M.W. Group, A review of human carcinogens\u2014Part C: metals, arsenic, dusts, and fibres","volume":"10","author":"Straif","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2022.06.008_b0040","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/carcin\/bgn059","article-title":"Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma","volume":"29","author":"Christensen","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2022.06.008_b0045","doi-asserted-by":"crossref","first-page":"e61253","DOI":"10.1371\/journal.pone.0061253","article-title":"Genetic Variants Associated with Increased Risk of Malignant Pleural Mesothelioma: A Genome-Wide Association Study","volume":"8","author":"Matullo","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lungcan.2022.06.008_b0050","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.1612074113","article-title":"High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma","volume":"113","author":"Yoshikawa","year":"2016","journal-title":"Proc. National Acad. Sci."},{"key":"10.1016\/j.lungcan.2022.06.008_b0055","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lungcan.2022.06.008_b0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jtho.2018.10.163","article-title":"Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects","volume":"14","author":"Guarrera","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2022.06.008_b0065","doi-asserted-by":"crossref","unstructured":"N. Alpert, M. van Gerwen, E. Taioli, Epidemiology of mesothelioma in the 21 st century in Europe and the United States, 40 years after restricted\/banned asbestos use, Transl. Lung Cancer Res. 9 (2019) S28\u2013S38. 10.21037\/tlcr.2019.11.11.","DOI":"10.21037\/tlcr.2019.11.11"},{"key":"10.1016\/j.lungcan.2022.06.008_b0070","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1164\/rccm.200806-955ED","article-title":"Screening for Mesothelioma","volume":"178","author":"van Meerbeeck","year":"2008","journal-title":"Am. J. Resp. Crit. Care."},{"key":"10.1016\/j.lungcan.2022.06.008_b0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.humpath.2017.07.015","article-title":"The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell\/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center","volume":"67","author":"Marchevsky","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.lungcan.2022.06.008_b0080","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lungcan.2022.06.008_b0085","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Modern Pathol."},{"key":"10.1016\/j.lungcan.2022.06.008_b0090","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.5858\/arpa.2018-0273-OA","article-title":"Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas","volume":"142","author":"Berg","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lungcan.2022.06.008_b0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/his.13872","article-title":"Cytoplasmic MTAP expression loss detected by immunohistochemistry correlates with 9p21 homozygous deletion detected by FISH in pleural effusion cytology of mesothelioma","volume":"75","author":"Hamasaki","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.lungcan.2022.06.008_b0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41379-019-0310-0","article-title":"MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma","volume":"33","author":"Chapel","year":"2019","journal-title":"Modern Pathol."},{"key":"10.1016\/j.lungcan.2022.06.008_b0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.lungcan.2004.08.003","article-title":"Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung","volume":"47","author":"Tsou","year":"2005","journal-title":"Lung Cancer."},{"key":"10.1016\/j.lungcan.2022.06.008_b0110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.lungcan.2007.06.015","article-title":"DNA methylation profile of 28 potential marker loci in malignant mesothelioma","volume":"58","author":"Tsou","year":"2007","journal-title":"Lung Cancer."},{"key":"10.1016\/j.lungcan.2022.06.008_b0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cancergencyto.2006.04.011","article-title":"Cytogenetic and molecular genetic changes in malignant mesothelioma","volume":"170","author":"Musti","year":"2006","journal-title":"Cancer Genet. Cytogen."},{"key":"10.1016\/j.lungcan.2022.06.008_b0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/path.4567","article-title":"Epigenetic down-regulation of integrin \u03b17 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma: ITGA7 hypermethylation in pleural mesothelioma","volume":"237","author":"Laszlo","year":"2015","journal-title":"J Pathol."},{"key":"10.1016\/j.lungcan.2022.06.008_b0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-08-2586","article-title":"Epigenetic Profiles Distinguish Pleural Mesothelioma from Normal Pleura and Predict Lung Asbestos Burden and Clinical Outcome","volume":"69","author":"Christensen","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2022.06.008_b0130","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1158\/0008-5472.CAN-09-1073","article-title":"Differentiation of Lung Adenocarcinoma, Pleural Mesothelioma, and Nonmalignant Pulmonary Tissues Using DNA Methylation Profiles","volume":"69","author":"Christensen","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2022.06.008_b0135","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1158\/0008-5472.CAN-09-1595","article-title":"Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma","volume":"69","author":"Goto","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2022.06.008_b0140","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jmoldx.2021.04.002","article-title":"DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics","volume":"23","author":"Bertero","year":"2021","journal-title":"J. Mol. Diagnostics."},{"key":"10.1016\/j.lungcan.2022.06.008_b0145","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jtho.2021.05.015","article-title":"DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-Analysis","volume":"16","author":"Vandenhoeck","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2022.06.008_b0150","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","article-title":"Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays","volume":"30","author":"Aryee","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.lungcan.2022.06.008_b0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-8935-8-6","article-title":"De novo identification of differentially methylated regions in the human genome","volume":"8","author":"Peters","year":"2015","journal-title":"Epigenet. Chromatin."},{"key":"10.1016\/j.lungcan.2022.06.008_b0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2164-14-293","article-title":"A data-driven approach to preprocessing Illumina 450K methylation array data","volume":"14","author":"Pidsley","year":"2013","journal-title":"BMC Genom."},{"key":"10.1016\/j.lungcan.2022.06.008_b0165","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/bioinformatics\/btv560","article-title":"missMethyl: an R package for analyzing data from Illumina\u2019s HumanMethylation450 platform","volume":"32","author":"Phipson","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.lungcan.2022.06.008_b0170","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s12859-019-3014-z","article-title":"RF_Purify: a novel tool for comprehensive analysis of tumor-purity in methylation array data based on random forest regression","volume":"20","author":"Johann","year":"2019","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.lungcan.2022.06.008_b0175","unstructured":"M. Kuhn, caret: Classification and Regression Training. R package version 6.0-71. https:\/\/CRAN.R-project.org\/package=caret, (n.d.)."},{"key":"10.1016\/j.lungcan.2022.06.008_b0180","first-page":"18","article-title":"Classification and Regression by RandomForest","volume":"2","author":"Liaw","year":"2002","journal-title":"R News."},{"key":"10.1016\/j.lungcan.2022.06.008_b0185","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41596-019-0251-6","article-title":"Machine learning workflows to estimate class probabilities for precision cancer diagnostics on DNA methylation microarray data","volume":"15","author":"Maros","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.lungcan.2022.06.008_b0190","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.lungcan.2022.06.008_b0195","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1038\/s41467-018-05570-1","article-title":"Pan-cancer deconvolution of tumour composition using DNA methylation","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2022.06.008_b0200","doi-asserted-by":"crossref","unstructured":"A.N. Husain, T.V. Colby, N.G. Ord\u00f3\u00f1ez, T.C. Allen, R.L. Attanoos, M.B. Beasley, K.J. Butnor, L.R. Chirieac, A.M. Churg, S. Dacic, F. Galateau-Sall\u00e9, A. Gibbs, A.M. Gown, T. Krausz, L.A. Litzky, A. Marchevsky, A.G. Nicholson, V.L. Roggli, A.K. Sharma, W.D. Travis, A.E. Walts,, M.R. Wick, Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group, Arch. Pathol. Lab Med. 142 (2018) 89\u2013108. 10.5858\/arpa.2017-0124-ra.","DOI":"10.5858\/arpa.2017-0124-RA"},{"key":"10.1016\/j.lungcan.2022.06.008_b0205","doi-asserted-by":"crossref","first-page":"eaaw8513","DOI":"10.1126\/scitranslmed.aaw8513","article-title":"Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases","volume":"11","author":"Jurmeister","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lungcan.2022.06.008_b0210","article-title":"Machine Learning Models Predict the Primary Sites of Head and Neck Squamous Cell Carcinoma Metastases Based on DNA Methylation","author":"Leitheiser","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.lungcan.2022.06.008_b0215","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2022.06.008_b0220","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41467-020-20603-4","article-title":"Sarcoma classification by DNA methylation profiling","volume":"12","author":"Koelsche","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2022.06.008_b0225","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41388-019-1063-4","article-title":"Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer","volume":"39","author":"Osei-Amponsa","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2022.06.008_b0230","first-page":"2169","article-title":"Forkhead\u2013box A1 regulates tumor cell growth and predicts prognosis in colorectal cancer","volume":"54","author":"Park","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lungcan.2022.06.008_b0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPT94JVWIHBKRD","article-title":"Diagnostic Usefulness of p16\/CDKN2A FISH in Distinguishing Between Sarcomatoid Mesothelioma and Fibrous Pleuritis","volume":"139","author":"Wu","year":"2013","journal-title":"Am. J. Clin. Pathol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950022200527X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950022200527X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:01:46Z","timestamp":1759237306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016950022200527X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":47,"alternative-id":["S016950022200527X"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.06.008","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}